Detalhe da pesquisa
1.
In Vitro Activity of Ceftibuten-Avibactam against ß-Lactamase-Positive Enterobacterales from the ATLAS Global Surveillance Program.
Antimicrob Agents Chemother
; 67(1): e0134622, 2023 01 24.
Artigo
Inglês
| MEDLINE | ID: mdl-36602322
2.
In vitro and in vivo activity of cefiderocol against Achromobacter spp. and Burkholderia cepacia complex, including carbapenem-non-susceptible isolates.
Antimicrob Agents Chemother
; 67(12): e0034623, 2023 12 14.
Artigo
Inglês
| MEDLINE | ID: mdl-37971240
3.
In Vitro Activity of Cefepime-Taniborbactam and Comparators against Clinical Isolates of Gram-Negative Bacilli from 2018 to 2020: Results from the Global Evaluation of Antimicrobial Resistance via Surveillance (GEARS) Program.
Antimicrob Agents Chemother
; 67(1): e0128122, 2023 01 24.
Artigo
Inglês
| MEDLINE | ID: mdl-36541767
4.
In vitro activity of cefiderocol against MBL-producing Gram-negative bacteria collected in North America and Europe in five consecutive annual multinational SIDERO-WT surveillance studies (2014-2019).
J Antimicrob Chemother
; 78(8): 2019-2027, 2023 08 02.
Artigo
Inglês
| MEDLINE | ID: mdl-37390312
5.
In Vitro Activity of Sulbactam-Durlobactam against Global Isolates of Acinetobacter baumannii-calcoaceticus Complex Collected from 2016 to 2021.
Antimicrob Agents Chemother
; 66(9): e0078122, 2022 09 20.
Artigo
Inglês
| MEDLINE | ID: mdl-36005804
6.
In Vitro Activity of Ceftibuten/VNRX-5236 against Urinary Tract Infection Isolates of Antimicrobial-Resistant Enterobacterales.
Antimicrob Agents Chemother
; 66(1): e0130421, 2022 01 18.
Artigo
Inglês
| MEDLINE | ID: mdl-34662183
7.
Ceftibuten-Ledaborbactam Activity against Multidrug-Resistant and Extended-Spectrum-ß-Lactamase-Positive Clinical Isolates of Enterobacterales from a 2018-2020 Global Surveillance Collection.
Antimicrob Agents Chemother
; 66(11): e0093422, 2022 11 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36286518
8.
In Vitro Susceptibility of Gram-Negative Pathogens to Cefiderocol in Five Consecutive Annual Multinational SIDERO-WT Surveillance Studies, 2014 to 2019.
Antimicrob Agents Chemother
; 66(2): e0199021, 2022 02 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34807757
9.
In Vitro Activity of Gepotidacin against Gram-Negative and Gram-Positive Anaerobes.
Antimicrob Agents Chemother
; 66(2): e0216521, 2022 02 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34930028
10.
Antimicrobial activity of ceftazidime-avibactam and comparators against levofloxacin-resistant Escherichia coli collected from four geographic regions, 2012-2018.
Ann Clin Microbiol Antimicrob
; 21(1): 13, 2022 Mar 21.
Artigo
Inglês
| MEDLINE | ID: mdl-35313912
11.
In Vitro Activity of WCK 5222 (Cefepime-Zidebactam) against Worldwide Collected Gram-Negative Bacilli Not Susceptible to Carbapenems.
Antimicrob Agents Chemother
; 64(12)2020 11 17.
Artigo
Inglês
| MEDLINE | ID: mdl-32928739
12.
In Vitro Activity of Sulbactam-Durlobactam against Acinetobacter baumannii-calcoaceticus Complex Isolates Collected Globally in 2016 and 2017.
Antimicrob Agents Chemother
; 64(4)2020 03 24.
Artigo
Inglês
| MEDLINE | ID: mdl-31988095
13.
Erratum for Karlowsky et al., "In Vitro Susceptibility of Gram-Negative Pathogens to Cefiderocol in Five Consecutive Annual Multinational SIDERO-WT Surveillance Studies, 2014 to 2019".
Antimicrob Agents Chemother
; 67(6): e0042723, 2023 Jun 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37154749
14.
In Vitro Activity of the Siderophore Cephalosporin, Cefiderocol, against Carbapenem-Nonsusceptible and Multidrug-Resistant Isolates of Gram-Negative Bacilli Collected Worldwide in 2014 to 2016.
Antimicrob Agents Chemother
; 62(2)2018 02.
Artigo
Inglês
| MEDLINE | ID: mdl-29158270
15.
In Vitro Activity of Meropenem-Vaborbactam against Clinical Isolates of KPC-Positive Enterobacteriaceae.
Antimicrob Agents Chemother
; 62(1)2018 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29084745
16.
Analysis of Potential ß-Lactam Surrogates To Predict In Vitro Susceptibility and Resistance to Ceftaroline for Clinical Isolates of Enterobacteriaceae.
J Clin Microbiol
; 56(4)2018 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29436424
17.
Activity of Ertapenem against Enterobacteriaceae in seven global regions-SMART 2012-2016.
Eur J Clin Microbiol Infect Dis
; 37(8): 1481-1489, 2018 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-29754209
18.
In Vitro Activity of Imipenem-Relebactam against Gram-Negative ESKAPE Pathogens Isolated by Clinical Laboratories in the United States in 2015 (Results from the SMART Global Surveillance Program).
Antimicrob Agents Chemother
; 61(6)2017 06.
Artigo
Inglês
| MEDLINE | ID: mdl-28320716
19.
In Vitro Activity of the Siderophore Cephalosporin, Cefiderocol, against a Recent Collection of Clinically Relevant Gram-Negative Bacilli from North America and Europe, Including Carbapenem-Nonsusceptible Isolates (SIDERO-WT-2014 Study).
Antimicrob Agents Chemother
; 61(9)2017 09.
Artigo
Inglês
| MEDLINE | ID: mdl-28630181
20.
In Vitro Activity of Aztreonam-Avibactam against Enterobacteriaceae and Pseudomonas aeruginosa Isolated by Clinical Laboratories in 40 Countries from 2012 to 2015.
Antimicrob Agents Chemother
; 61(9)2017 09.
Artigo
Inglês
| MEDLINE | ID: mdl-28630192